Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Cost-effectiveness of gemcitabine in stage IV...
Conference

Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module.

Abstract

Statistics Canada (Ottawa, Ontario, Canada) is in the process of developing the Population Health Model to simulate the health and common illnesses of Canadians. The Population Health Model incorporates a lung cancer module that is based on contemporary Canadian practice. This microsimulation model can be used to estimate the total direct care costs of treating all lung cancer cases diagnosed in Canada and to evaluate the cost and …

Authors

Evans WK

Volume

24

Publication Date

April 1997

Conference proceedings

Seminars in Oncology

Issue

2 Suppl 7

ISSN

0093-7754